Filing Details

Accession Number:
0001209191-16-095025
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-02 19:16:46
Reporting Period:
2016-02-01
Filing Date:
2016-02-02
Accepted Time:
2016-02-02 19:16:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509190 Aratana Therapeutics Inc. PETX Pharmaceutical Preparations (2834) 383826477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201050 A Craig Tooman C/O Aratana Therapeutics, Inc.
11400 Tomahawk Creek Parkway, Suite 340
Leawood KS 66211
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-02-01 2,806 $3.36 102,424 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015, and represents shares sold to cover tax liability incident to the vesting of shares of restricted stock. This sale constitutes the final sale under such trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.33 to $3.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.